Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of Luofushan Baicao oil in preparation of medicine for preventing or treating respiratory system infectious diseases

A technology for infectious diseases and respiratory system, applied in respiratory system diseases, drug combination, drug delivery, etc., can solve the problem of time-consuming and time-consuming research and development cycle, and achieve convenient use, non-addiction, and safety guarantee. Effect

Active Publication Date: 2022-01-28
GUANGDONG LUOFUSHAN SINOPHARM
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, new drug development is a time-consuming process, not only the research and development cycle, but also the mass production after marketing approval is a time-consuming project

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Luofushan Baicao oil in preparation of medicine for preventing or treating respiratory system infectious diseases
  • Application of Luofushan Baicao oil in preparation of medicine for preventing or treating respiratory system infectious diseases
  • Application of Luofushan Baicao oil in preparation of medicine for preventing or treating respiratory system infectious diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] This example provides the use of Luofushan Baicao Oil in the preparation of medicines for preventing or treating coronavirus infection or respiratory infectious diseases caused by coronavirus infection. The medicine is an external preparation, wherein Luofushan Baicao Oil contains the following Components in parts by weight: 25 parts of camphor, 240 parts of methyl salicylate, 90 parts of turpentine oil, 220 parts of peppermint oil, 11 parts of clove basil oil, 120 parts of camphor oil, 14 parts of star anise oil, 15 parts of cinnamon oil, borneol 2 parts, menthol 25 parts, eucalyptus oil 35 parts, tea oil extract 60 parts.

[0047] The tea oil extract is extracted from the tea oil composition. Specifically, the tea oil composition is crushed into a coarse powder, passed through a 30-mesh sieve, mixed evenly, added with 2 times the volume of tea oil, and soaked at 45°C for 25 day, filtered while it was hot, and the filtrate was left to cool to room temperature to obtain...

Embodiment 2

[0051] This example provides the use of Luofushan Baicao Oil in the preparation of medicines for preventing or treating coronavirus infection or respiratory infectious diseases caused by coronavirus infection. The medicine is an external preparation, wherein Luofushan Baicao Oil contains the following Components in parts by weight: 30 parts of camphor, 280 parts of methyl salicylate, 100 parts of turpentine oil, 300 parts of peppermint oil, 18 parts of clove basil oil, 180 parts of camphor oil, 20 parts of star anise oil, 25 parts of cinnamon oil, borneol 3 parts, menthol 30 parts, eucalyptus oil 45 parts, tea oil extract 100 parts.

[0052] The camellia oil extract is extracted from the camellia oil composition. Specifically, the camellia oil composition is pulverized into a coarse powder, passed through a 30-mesh sieve, mixed and added with 3 times the volume of camellia oil, and soaked at 60°C for 10 day, filtered while it was hot, and the filtrate was left to cool to room ...

Embodiment 3

[0056] This example provides the use of Luofushan Baicao Oil in the preparation of medicines for preventing or treating coronavirus infection or respiratory infectious diseases caused by coronavirus infection. The medicine is an external preparation, wherein Luofushan Baicao Oil contains the following Components in parts by weight: 20 parts of camphor, 200 parts of methyl salicylate, 80 parts of turpentine oil, 200 parts of peppermint oil, 10 parts of clove basil oil, 100 parts of camphor oil, 10 parts of star anise oil, 10 parts of cinnamon oil, borneol 2 parts, menthol 20 parts, eucalyptus oil 30 parts, tea oil extract 40 parts.

[0057] The tea oil extract is extracted from the tea oil composition. Specifically, the tea oil composition is crushed into coarse powder, passed through a 30-mesh sieve, mixed evenly, added with 2 times the volume of tea oil, and soaked at 50°C for 15 day, filtered while it was hot, and the filtrate was left to cool to room temperature to obtain c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of Luofushan Baicao oil in preparation of a medicine for preventing or treating coronavirus infection or respiratory system infectious diseases caused by coronavirus infection. The Luofushan Baicao oil is prepared from the following components in parts by weight: 20-40 parts of camphor, 200-300 parts of methyl salicylate, 80-110 parts of turpentine, 200-300 parts of dementholized peppermint oil, 10-20 parts of eugenel type basil oil, 100-200 parts of camphor wood oil, 10-30 parts of star anise oil, 10-30 parts of cinnamon oil, 2-4 parts of borneol, 20-35 parts of menthol, 30-50 parts of eucalyptus oil and 40-120 parts of a tea oil extract. All the medicinal materials in the Luofushan Baicao oil are matched with one another and have a synergistic effect, so that the Luofushan Baicao oil treats both symptoms and root causes, strengthens the body resistance to eliminate pathogenic factors, takes effect quickly, has a good effect and has a very good clinical curative effect on respiratory system infectious diseases caused by coronavirus infection.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the use of Luofushan Baicao Oil in the preparation of medicines for preventing or treating coronavirus infection or respiratory infectious diseases caused by coronavirus infection. Background technique [0002] Human coronaviruses were isolated in 1965, but their knowledge is currently quite limited. In 1967, Mclntosh and others isolated a batch of viruses from cold patients with human embryo trachea culture, and its representative strain was OC43 strain. In 1968, Almeida et al. carried out morphological studies on these viruses. Electron microscope observations found that the envelopes of these viruses had spikes similar to the corona, so they proposed to name these viruses as coronaviruses. In 1965, Tyrrell and Bynoe used the ciliated trachea tissue of embryos to cultivate coronaviruses for the first time. This virus can be seen as a corona-like peripheral crown under an el...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/61A61K36/896A61K36/9068A61K9/72A61K9/00A61P31/14A61P11/00A61P29/00A61P11/02A61P11/04A61K31/045A61K31/125A61K31/618
CPCA61K31/125A61K31/618A61K36/15A61K36/534A61K36/53A61K36/54A61K36/57A61K31/045A61K36/61A61K36/758A61K36/75A61K36/286A61K36/185A61K36/28A61K36/80A61K36/232A61K36/258A61K36/47A61K36/9064A61K36/237A61K36/9068A61K36/752A61K36/8905A61K36/287A61K36/85A61K36/346A61K36/268A61K36/59A61K36/754A61K36/238A61K36/539A61K36/72A61K36/233A61K36/12A61K36/48A61K36/538A61K36/704A61K36/74A61K36/855A61K36/748A61K36/898A61K36/282A61K36/483A61K36/285A61K36/533A61K36/535A61K36/21A61K36/14A61K36/78A61K36/11A61K36/575A61K36/27A61K36/355A61K36/17A61K36/896A61K36/70A61K36/69A61K9/007A61K9/0014A61P31/14A61P11/00A61P29/00A61P11/02A61P11/04A61K2300/00
Inventor 黄炜忠毛鑫叶耀良陈新泉廖志钟
Owner GUANGDONG LUOFUSHAN SINOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com